Missed Sasol's 136% Gain? Here's What Investors Got Right

If Sasol was on your watchlist rather than in your portfolio, the return may sting. For Sasol shareholders, the return from the start of the year was 135.8%, including dividends. That kind of move raises a simple question. What, if anything, in the early 2026 research about surfactant commercialization and higher margins could have helped you treat Sasol as a real contender rather than just another carbon heavy producer?

On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.

This theme extends beyond Sasol. See which of 41 power grid technology and infrastructure stocks may still merit a closer look.

The Two Sasol Stories Investors Had To Weigh

Sasol shares cost ZAR106 at the start of the period, and investors were effectively choosing between two sharply different stories about where the business could go next.

The bullish narrative put fair value at ZAR134, 26% above the start price. It leaned on assumptions of 4.0% annual revenue growth, profit margins reaching 8.1%, and a future P/E of 7.1x as surfactant commercialization and margin improvement took hold.

The bearish view set fair value at ZAR70, 34% below the start price. It focused on rising climate regulation, stranded asset risk tied to coal heavy operations, and the possibility that intense global competition would crush long term profitability.

What The Results Changed For The Sasol Thesis

The clearest new fact was Sasol’s H2 2026 net margin of 8.0%, compared with 1.7% in H2 2025. This pointed toward the bullish margin story. Revenue and net income were both reported higher in the same comparison. At the same time, news on the Mozambique gas talks highlighted that fossil fuel exposure remains central. Overall, the evidence cut both ways.

The key assumption this period turned on was profitability per rand of sales. When you assess another stock, track whether the net margin trend in reported results matches the margin profile baked into the upbeat case you are testing.

What Sasol's ZAR247 Price Assumes Today

Sasol now trades at ZAR247, up sharply from ZAR106 at the start of the year. The selected cautious Narrative places its Fair Value below that market level, arguing that recent execution progress and decarbonisation plans may already be heavily reflected in the quote.

The question for anyone looking at Sasol now is what must keep working for the current price to hold. This Narrative argues you would be counting on cost cuts, reliability gains and portfolio changes to keep translating into free cash flow that steadily reduces net debt despite climate and project risks.

"Key Takeaways: Bearish analysts expect Sasol's heavy dependence on coal based fuels and chemicals to keep exposing the business to tightening climate rules, further asset impairments and pressure on long term profitability, despite ongoing renewables and decarbonisation projects. The main requirement is that Sasol converts its cost cutting, production reliability gains at Secunda and portfolio reset in International Chemicals into durable free cash flow that brings net debt below the stated dividend threshold, while managing gas project and regulatory risks."

One Narrative has put a figure on that disagreement. → See the Narrative with its lower Fair Value, assumptions and all

Which Company Could Surprise You Next?

You may be late to this rally, but that does not have to mean arriving late to every opportunity. Start with companies whose prices leave room for a different view of their future. Here are three trading below our estimates.

• Company 1 - 23% below our estimate - turns a multi-modal cardiometabolic and obesity pipeline into expanded treatment availability.
• Company 2 - 37% below our estimate - shifts its hospital equipment mix toward consumables and workflow tools while reducing defects.
• Company 3 - 28% below our estimate - builds hardware-agnostic oncology software that converts licenses into ongoing support contracts.

Three companies from the same screener. Open all 224 potentially undervalued companies →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com